Christopher Brett Primiano, SVP, Operations, Business Development, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 53,440 shares at $9.93 ($550K) on 2017-12-12, disclosed to the SEC on 2017-12-13.
Open-market sale of $550k KPTI by SVP, Operations, Business Development, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.88 | 10,042 | $109K | 19.9% |
| 2 | $10.88 | 10,042 | $109K | 19.9% |
| 3 | $9.59 | 644 | $6K | 1.1% |
| 4 | $9.93 | 16,356 | $162K | 29.6% |
| 5 | $9.93 | 16,356 | $162K | 29.6% |
| Total | $10.28 avg | 53,440 |
| $550K |
| 100% |
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |